A video conference was held with the participation of representatives of the Pharmaceutical Industry Development Agency, the Embassy of Uzbekistan in South Korea, and the management of Huscion, which conducts research on the development of new innovative formulas.

The conference discussed issues of scientific exchange, technology transfer, clinical and pre-clinical trials, as well as cooperation in the development of new drugs.

It should be noted that the company is conducting clinical trials of many drugs, and after the tests intends to visit Uzbekistan to hold talks on cooperation. As previously agreed, the issue of organizing clinical trials of the Korean company in Uzbekistan in cooperation with research institutes under the Agency was also in the focus of attention.

Sardor Kariev, head of the Pharmaceutical Industry Development Agency, suggested setting up a working group to develop a roadmap for implementing the agreements and holding another video conference to discuss the work to be done in the first half of February.

An online cooperation agreement was then signed between the head of the Agency and the CEO of Huscion.

Press Service
Pharmaceutical Industry Development Agency